PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer
Authors
Keywords
-
Journal
npj Precision Oncology
Volume 6, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-29
DOI
10.1038/s41698-022-00291-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer
- (2021) Judit Börcsök et al. CLINICAL CANCER RESEARCH
- Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2
- (2021) Kim A. Reiss et al. JOURNAL OF CLINICAL ONCOLOGY
- Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial
- (2021) Suzanne Carreira et al. Cancer Discovery
- ATM Loss Confers Greater Sensitivity to ATR Inhibition than PARP Inhibition in Prostate Cancer
- (2020) Shahrzad Rafiei et al. CANCER RESEARCH
- Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: analysis from the phase 2 TRITON2 study
- (2020) Wassim Abida et al. CLINICAL CANCER RESEARCH
- Detection of molecular signatures of homologous recombination deficiency in prostate cancer with or without BRCA1/2 mutations
- (2020) Zsofia Sztupinszki et al. CLINICAL CANCER RESEARCH
- The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication
- (2020) Madalena Tarsounas et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Biomarker-Guided Development of DNA Repair Inhibitors
- (2020) James M. Cleary et al. MOLECULAR CELL
- Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
- (2020) Wassim Abida et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
- (2020) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors
- (2020) Antje Neeb et al. EUROPEAN UROLOGY
- Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
- (2019) Piper Nicolosi et al. JAMA Oncology
- Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity
- (2019) Aleksandra I. Adamovich et al. PLoS Genetics
- TOPARP-B: A phase II randomized trial of the poly(ADP)-ribose polymerase (PARP) inhibitor olaparib for metastatic castration resistant prostate cancers (mCRPC) with DNA damage repair (DDR) alterations.
- (2019) Joaquin Mateo et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The long tail of oncogenic drivers in prostate cancer
- (2018) Joshua Armenia et al. NATURE GENETICS
- A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
- (2017) Paz Polak et al. NATURE GENETICS
- Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
- (2016) M. L. Telli et al. CLINICAL CANCER RESEARCH
- PALB2,CHEK2andATMrare variants and cancer risk: data from COGS
- (2016) Melissa C Southey et al. JOURNAL OF MEDICAL GENETICS
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
- (2015) Douglas F. Easton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
- (2015) Rohit Prakash et al. Cold Spring Harbor Perspectives in Biology
- Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data
- (2014) F. Favero et al. ANNALS OF ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search